Organization · Venture Capital
The Vertical Group
The Vertical Group is a venture capital firm specializing in medical technology and biotechnology investments. Based in Basking Ridge, New Jersey, with an office in San Mateo, California, it has been active since 1988.
Overview
What The Vertical Group does
What The Vertical Group is
The Vertical Group is a venture capital firm specializing in medical technology and biotechnology investments. Based in Basking Ridge, New Jersey, with an office in San Mateo, California, it has been active since 1988.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 1988
- Approximate age
- About 38 years
- Structured capabilities
- Funder
- Last reviewed
- May 1, 2026
Official channels
Find The Vertical Group elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Vertical Group as a funder
Investment thesis
The Vertical Group focuses on investing in medical technology and biotechnology, emphasizing cost-effectiveness and improved patient outcomes. Their expertise in regulated product development and commercialization makes them a valuable partner for healthcare companies.
Focus narrative
The Vertical Group invests primarily in the healthcare sector, focusing on medical technology and biotechnology. They engage in early-stage angel financings as well as both early and later-stage venture capital financings, with investment sizes ranging from $250,000 to $5,000,000. The firm prioritizes investments that demonstrate cost-effectiveness alongside improved patient outcomes.
Value beyond capital
The Vertical Group adds value to its portfolio companies through deep operational and investing expertise in medical devices and biotech. Their partners leverage extensive experience in sales, marketing, R&D, regulatory affairs, and transaction structuring to support portfolio companies in navigating the complexities of healthcare product development and commercialization.
Terms and economics
- Typical check
- $250,000–$5,000,000
Focus and fit
- Stages
- Angel · Seed · Series A · Growth Equity
- Sectors
- Healthcare · Biotech · Medical Devices · Digital Health · Diagnostics
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Kyphon Corporation and Masimo Corporation
Portfolio context
Notable portfolio companies include: MicroTransponder: Developer of the Vivistim Paired VNS system for stroke recovery. Luminopia: Creator of a digital therapeutic for neuro-visual disorders, recognized as one of TIME’s Best Inventions of 2023. Radiaction Medical: Focuses on radiation protection for medical staff during procedures. Trace Medical: Distributes home dialysis systems. Historic investments include Kyphon Corporation, acquired by Medtronic, and Masimo Corporation, a leader in pulse oximetry technology.
Common questions
What to know about The Vertical Group
Upseed classifies The Vertical Group under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 1, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.